{
    "SPADE_N_14401": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14401",
            "Peptide Name": "An-cecB-1 (An-cecB fragment, Synthetic AMPs, XXA, UCLL1c; Other derivatives: An-cecB-2 and An-cecB-3)",
            "Source": "amino acid truncation, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "APRWKFGKRLEKLGRNVF",
            "Sequence Length": 18,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiparasitic"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2202.61,
            "PI": 11.73,
            "Hydrophobicity": -0.91,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Lou J, Zhang D, Wu J, Zhu G, Zhang M, Tang J, Fang Y, He X, Cao J. 2024",
                    "Reference": "Antimicrob Agents Chemother. 2024 Jun 14:e0031124. doi: 10.1128/aac.00311-24.PubMed",
                    "Title": "Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes."
                }
            ],
            "Frequent Amino Acids": "KRF",
            "Absent Amino Acids": "CDHIMOQSTUY",
            "Basic Residues": 6,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 8,
            "Polar Residues": 9,
            "Positive Residues": 6,
            "Negative Residues": 1,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (52.94%) toAn-cecBK=A: 18%, R=L: 12%. GRAVY: -0.309; Mol Wt: 3854.68; mol formula: C181H300N53O39; mol ex coeff: 7040.Activity: inhibited P. falciparum 3D7 (IC50 68.63 uM). In addiiton, it inhibited bacterial growth S.aureus (MIC >200 uM), B. subtilis (MIC 18.94 uM), and E. coli (MIC 12.7 uM).Animal model:mouse: showed a dose-dependent inhibition by 17.03%, 39.35%, and 54.19% when IP treated at 10, 20, and 50 mg/kg (4 hpi), respectively, in P. berghei-infected mice (IP).SAR: An-cecB-2 (seq: RAAKKALPVIAGYKAL) and An-cecB-3 (seq: GKRLEKLGRNVFRAAKK) showed small inhibitory effects at 200 uM, indicating the importance of the N-terminal sequence for peptide activity.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02712",
                    "Similarity": 1.0,
                    "Sequence": "APRWKFGKRLEKLGRNVFRAAKKALPVIAGYKAL"
                },
                {
                    "SPADE_ID": "SPADE_UN_26234",
                    "Similarity": 1.0,
                    "Sequence": "APRWKFGKRLEKLGRNVF"
                },
                {
                    "SPADE_ID": "SPADE_N_07528",
                    "Similarity": 0.7777777777777778,
                    "Sequence": "MNFTKLFIMVAIAVLLIAGIQPVEAAPRMEIGKRREKLGRNVFKAAKKALPVIAGYKALG"
                }
            ]
        }
    }
}